OTOIMMUNE LTD
Company number 15799123 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£177,505
Balance sheet as at 2024-12-31
What it does
The principal activity of the Company is the development and provision of tools and resources to support individuals affected by autoimmune conditions.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2024-06-24
- Employees
- 2 (2024 accounts)
- Registered office
- 20 Wenlock Road, London, England, N1 7GU
- Postcode
- N1 7GU
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-06-23
- Next due by
- 2027-07-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current
Jason Alexander, Dr MELLAD
Director
Daniel Edward ROOKE
Director
Among its peers
Top 25%
by shareholders' funds, of 66 similar companies in N
Trading since 2024.
No.9 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 9 among research and experimental development on biotechnology in London.